NCT05984927

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2023-09-08Est. Completion: 2026-05-27

Enrollment target: 20 participants

Locations

Cincinnati Eye Institute, Cincinnati, Ohio, United States
Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
Sunnybrook Ophthalmology and Vision Services, Toronto, Ontario, Canada
Vitreous Retina Macula Specialists of Toronto, Toronto, Ontario, Canada

Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage

The centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for …

Bonn, GermanyEst. completion Dec 2028

Age Related Macular Degeneration

Neovascular age-related macular degeneration (nAMD), also called wet AMD, can cause serious vision loss. While anti-VEGF…

Singapore, SingaporeEst. completion Jun 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.